These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25064732)

  • 1. Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
    Han L; Zhang G; Zhang N; Li H; Liu Y; Fu A; Zheng Y
    Med Oncol; 2014 Sep; 31(9):129. PubMed ID: 25064732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
    Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
    Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G; Zhang J; Chen X
    J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
    Zhang YK; Sun B; Sui G
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
    Xu X; Zhu S; Tao Z; Ye S
    Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.
    Ye XW; Yu H; Jin YK; Jing XT; Xu M; Wan ZF; Zhang XY
    Clin Respir J; 2015 Jan; 9(1):27-33. PubMed ID: 24405893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum miR-25 in non-small-cell lung cancer.
    Li J; Yu M; Liu Z; Liu B
    Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer.
    Ding H; Wen W; Ding Q; Zhao X
    Cancer Control; 2020; 27(1):1073274820964783. PubMed ID: 33104396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
    Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
    Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
    Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.